Logo image
Prof. Dr. med. habil. Cezary Szczylik working place, European Health Center Otwock
Prof. Dr. med. habil. Cezary Szczylik
Excellent
AiroScore
9.20

Prof. Dr. med. habil. Cezary Szczylik

clinical oncology and hematology
clinical oncology and hematology
User ScoreRatingPublicationsOnline Consultations
96%9.2/10280Yes

Overview

Country, City
Poland, Otwock
Health facility
European Health Center Otwock
Medical unit
Department of clinical oncology

About the doctor

Prof. Dr. med. habil. Cezary Szczylik is an esteemed specialist in clinical oncology, cancer chemotherapy, and internal medicine, focusing on hematology. He currently serves as the head of the Oncology Clinic at the European Health Center Otwock in Poland. With years of experience in the field, Prof. Szczylik has made significant contributions to the medical community and has a remarkable list of 280 scientific publications. One of the most exciting aspects of Prof. Szczylik's career is his role as the president of the Experimental and Clinical Oncology Foundation and as a co-founder of the School of Molecular Medicine. This highlights his commitment to advancing cancer research and finding innovative patient treatments. He is also a member of several esteemed medical societies, including the Polish Oncological Society, showcasing his expertise and dedication to his field. Prof. Szczylik's research and clinical work have focused on various types of cancer, including renal cell carcinoma and ovarian cancer. His publications demonstrate his in-depth knowledge and significant contributions to the understanding and treatment of these diseases. His expertise and dedication make him an exceptional doctor, providing patients with high-quality care and access to the latest advancements in oncology.

Skills & Expertise

cancer
carcinoma
cell carcinoma
renal cell carcinoma
bone
transplantation
bone marrow
breast
sunitinib
breast cancer
ovarian cancer
sorafenib
chemotherapy
bone marrow transplantation
renal cancer
everolimus
colorectal
metastases
colorectal cancer
oncology
stem cell transplantation
hematopoietic stem
epithelial ovarian cancer
hematopoiesis
malignant
cyclophosphamide
peritoneal dialysis
peritoneal cancer
metastatic colorectal cancer
cabozantinib
pazopanib
pembrolizumab
cisplatin
hematology
brca1positive breast cancers
metastatic breast cancer
melanoma
lymphoma
leukemia cell
glioma
bone metastases
brca2 mutation
brain metastases
prostate cancer
castrateresistant prostate cancer
ovarian cancer cells
pancreatic neuroendocrine neoplasm
her2positive metastatic breast
triplenegative breast cancer
pancreas

Resume

CV (Curriculum Vitae)

Education
  • Specialist in clinical oncology
  • Specialist in cancer chemotherapy
  • Specialist in internal medicine
  • Habilitation in the field of hematology and the title of full professor in clinical oncology
Experience
  • Head of the Oncology Clinic of the Postgraduate Medical Education Center
  • Head of the Department of Clinical Oncology and Chemotherapy European Health Center Otwock
Awards & Memberships
  • President of the Experimental and Clinical Oncology Foundation
  • Co-founder of the School of Molecular Medicine
  • Member of the Polish Oncological Society
  • Member of the scientific council of the Medical Centre of Postgraduate Education
  • Member of the Program Board of the Jolanta Kwaśniewska Foundation “Communication without barriers”
  • Consultant of the Steering Committee of the strategic research and development program "Prevention and treatment of lifestyle diseases" - Strategmed
  • 2005 Awarded the Knight's Cross of the Order of Polonia Restituta

Languages

English flag
English
Polish flag
Polish

Publications

Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma.

1 September, 2023

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.

22 July, 2023

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.

11 May, 2023

Location

Borowa, 14, 05-400 Otwock, Poland

FAQ

What is the specialization of Prof. Dr. med. habil. Cezary Szczylik?

The primary specialization of the doctor is clinical oncology and hematology.

What is the rating of the doctor?

What topics does Prof. Dr. med. habil. Cezary Szczylik expert at?

The doctor has excellent knowledge in cancer, carcinoma, cell carcinoma, renal cell carcinoma, bone.

Is the specialist involved in the research?

Does the specialist offer online consultations?

Yes, Prof. Dr. med. habil. Cezary Szczylik performs virtual appointments and offers a second medical opinion service.

Prof. Dr. med. habil. Cezary Szczylik
Prof. Dr. med. habil. Cezary Szczylik

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. habil. Cezary Szczylik

Similar Doctors

Excellent
AiroScore
9.30
Excellent
AiroScore
10.00
University Hospital Charite Berlin
pediatrics, hematology, oncology, pediatric intensive care
Excellent
AiroScore
10.00
University Hospital Charite Berlin
oncology, haematology, biological therapy of cancer
Excellent
AiroScore
10.00
University Hospital Charite Berlin
haematology, oncology, leukaemia research, tumor immunology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
gynecology, breast cancer, plastic, and reconstructive operations in gynecology
Excellent
AiroScore
9.90
University Hospital Schleswig-Holstein Kiel
robot-assisted surgery, obstetrics, operative gynecology, and gynecological oncology
Excellent
AiroScore
9.90
Excellent
AiroScore
9.90
University Hospital Schleswig-Holstein Kiel
internal medicine, hematology, and internal oncology
Excellent
AiroScore
9.90